| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/10/1997 | WO1997012859A1 Succinimide and maleimide cytokine inhibitors |
| 04/10/1997 | WO1997012853A1 Dimer-selective rxr modulators and methods for their use |
| 04/10/1997 | WO1997012633A1 Dendritic cell stimulatory factor |
| 04/10/1997 | WO1997012617A1 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods |
| 04/10/1997 | WO1997009998A3 Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors |
| 04/10/1997 | WO1997002830A3 Use of indigestible oligosaccharides to treat and prevent otitis media in humans |
| 04/10/1997 | WO1996026961A3 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use |
| 04/10/1997 | DE19537334A1 New piperidine carboxylic acid and pyrrolidine carboxylic acid derivs. |
| 04/10/1997 | CA2234229A1 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods |
| 04/10/1997 | CA2234059A1 Novel c-mpl receptor agonists |
| 04/10/1997 | CA2233888A1 Dimer-selective rxr modulators and methods for their use |
| 04/10/1997 | CA2233300A1 A paf-acetylhydrolase and use in therapy |
| 04/10/1997 | CA2232865A1 The use of flt3 ligand to generate dendritic cells |
| 04/10/1997 | CA2229434A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
| 04/10/1997 | CA2226980A1 Purine and guanine derivatives |
| 04/10/1997 | CA2226958A1 Purine and guanine derivatives as pnp inhibitors |
| 04/10/1997 | CA2187485A1 Peptide and collagen contraction inhibitor |
| 04/10/1997 | CA2187392A1 Antiadhesive piperidine-and pyrrolidinecarboxylic acids |
| 04/09/1997 | EP0767178A1 Protein which induces interferon-gamma production by immunocompetent cell |
| 04/09/1997 | EP0766699A1 Esterified polyanionic cyclodextrins as smooth muscle cell proliferation inhibitors |
| 04/09/1997 | EP0766695A1 Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders |
| 04/09/1997 | EP0766693A1 Novel parasite protease genes and proteins |
| 04/09/1997 | EP0766687A1 Phosphinic acid derivatives with metallopeptidase inhibitory activity |
| 04/09/1997 | EP0766682A1 Protein kinase c inhibitors |
| 04/09/1997 | EP0766676A1 Compounds for and method of inhibiting phosphodiesterase iv |
| 04/09/1997 | EP0766674A1 New hiv protease inhibitors |
| 04/09/1997 | EP0766672A1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
| 04/09/1997 | EP0766670A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 04/09/1997 | EP0766669A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 04/09/1997 | EP0766668A1 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudormophs thereof |
| 04/09/1997 | EP0766665A2 Metalloproteinase inhibitors |
| 04/09/1997 | EP0766664A2 Metalloproteinase inhibitors |
| 04/09/1997 | EP0766565A1 Medical use of bromelain |
| 04/09/1997 | EP0766559A1 Cannabinoid receptor antagonists |
| 04/09/1997 | EP0766557A1 Topical compositions comprising n-acetyl-l-cysteine |
| 04/09/1997 | EP0705263B1 Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 04/09/1997 | EP0651739B1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 04/09/1997 | EP0638071B1 Heterocyclic carbonic acid derivatives which bind to retinoid receptors (rar) |
| 04/09/1997 | EP0625911B1 Malaria treatments |
| 04/09/1997 | EP0606210B1 Hepatocyte growth stimulation with hepatocyte growth factor and gamma-interferon |
| 04/09/1997 | EP0599890B1 Geneserine derivatives as cholinesterase inhibitors |
| 04/09/1997 | CN1147260A Neurokinine (tachykinine) antagonists |
| 04/09/1997 | CN1147250A Naphthalene derivs. as prostaglandin I2 agonists |
| 04/09/1997 | CN1147201A Halomethyl amides as IL-1 'beta' protease inhibitors |
| 04/09/1997 | CN1034501C Method for preparing (Benzhydryloxyethylpiperidyl) aliphatic acid derivs. |
| 04/08/1997 | USRE35492 Wound treatment employing biologically active ion channel forming peptides and proteins |
| 04/08/1997 | US5618947 Separating the racemic mixture by chromatography |
| 04/08/1997 | US5618941 Benzenealkanoic acids for cardiovascular diseases |
| 04/08/1997 | US5618939 Reacting of an amine nucleophile with an activated glycidylcompound in presence of a strong base at low temperature |
| 04/08/1997 | US5618850 Hydroxy-acid cosmetics |
| 04/08/1997 | US5618847 Medicinal feed for the systemic treatment of ectoparasitic and ectobacterial diseases of fish |
| 04/08/1997 | US5618844 Matrix metalloproteinase inhibitor |
| 04/08/1997 | US5618839 Retinoid-like compounds |
| 04/08/1997 | US5618833 1-benzyl-1,3-dihydroindol-2-one derivatives, their preparation and the pharmaceutical compositions in which they are present |
| 04/08/1997 | US5618825 Combinatorial sulfonamide library |
| 04/08/1997 | US5618824 Treatment of obsessive-compulsive disorders with 5-HT2 antagonists |
| 04/08/1997 | US5618823 Glutathione as chemoprotective agent |
| 04/08/1997 | US5618814 Trisubstituted pyrimido [5,4-d] pyrimidines for modulating multi-drug resistance and pharmaceutical compositions containing these compounds |
| 04/08/1997 | US5618812 Benzodiazepine derivatives |
| 04/08/1997 | US5618808 Benzothiazepine and benzoxazepine derivatives as cholecystokinin receptor antagonists |
| 04/08/1997 | US5618803 Targeted drug delivery via phosphonate derivatives |
| 04/08/1997 | US5618794 α-glycosyl derivative of catecholamine or its salt, and its preparation and uses |
| 04/08/1997 | US5618792 Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase |
| 04/08/1997 | US5618698 Growing host cells transformed or transfected with specified isolated dna sequence, isolating erythropoietin product |
| 04/08/1997 | US5618558 Fatty acid treatment |
| 04/08/1997 | US5618553 Contacting localized region of eye with polymer implant having reversibly associated modulating agent which is released at rate such that target cells are primarily affected |
| 04/08/1997 | US5618549 Bone diseases such as osteoporosis |
| 04/08/1997 | US5618545 Skin-cosmetic composition |
| 04/08/1997 | US5618534 Isolated antigen endo glyx-1 |
| 04/08/1997 | US5618339 Substance prepared from animal bones by liming, neutralization, thermal extraction, condensation, dehydration to obtain gelatin which is deproteinized through non-heat or low temperature process |
| 04/03/1997 | WO1997012060A1 ARF-p19, A NOVEL REGULATOR OF THE MAMMALIAN CELL CYCLE |
| 04/03/1997 | WO1997012055A1 Product and process to regulate actin polymerization |
| 04/03/1997 | WO1997012050A1 Method for transferring genes to the heart using aav vectors |
| 04/03/1997 | WO1997012043A2 Hcv ns3 protein fragments having helicase activity and improved solubility |
| 04/03/1997 | WO1997012036A2 Bone stimulating factor |
| 04/03/1997 | WO1997011950A1 Metal complexes as cysteine protease inhibitors |
| 04/03/1997 | WO1997011716A1 Manipulation of non-terminally differentiated cells using the notch pathway |
| 04/03/1997 | WO1997011698A1 ALPHA 1b ADRENERGIC RECEPTOR ANTAGONISTS |
| 04/03/1997 | WO1997011696A1 Transdermal administration of ropinirole and analogs thereof |
| 04/03/1997 | WO1997011695A1 Substituted indolylpropyl-piperazine derivatives as 5-ht1dalpha agonists |
| 04/03/1997 | WO1997011693A1 Guanidino protease inhibitors |
| 04/03/1997 | WO1997011684A1 Use of heparinases to decrease inflammatory responses |
| 04/03/1997 | WO1997011668A2 TUMOR NECROSIS FACTOR ALPHA (TNF-α) INHIBITING PHARMACEUTICALS |
| 04/03/1997 | WO1997011604A1 Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains |
| 04/03/1997 | WO1997005771A3 Lysosomal proteins produced in the milk of transgenic animals |
| 04/03/1997 | WO1996040948A3 Resistance to viruses and viroids in transgenic plant and animal hosts expressing dsrna-binding protein |
| 04/03/1997 | CA2233344A1 Guanidino protease inhibitors |
| 04/03/1997 | CA2233343A1 Use of heparinases to decrease inflammatory responses |
| 04/03/1997 | CA2233334A1 Transdermal administration of ropinirole and analogs thereof |
| 04/03/1997 | CA2233167A1 Method for transferring genes to the heart using aav vectors |
| 04/03/1997 | CA2232821A1 Metal complexes as cysteine protease inhibitors |
| 04/03/1997 | CA2232260A1 Substituted indolylpropyl-piperazine derivatives as 5-ht1dalpha agonists |
| 04/03/1997 | CA2232138A1 Alpha 1b adrenergic receptor antagonists |
| 04/03/1997 | CA2231764A1 Tumor necrosis factor alpha (tnf-.alpha.) inhibiting pharmaceuticals |
| 04/03/1997 | CA2230121A1 Product and process to regulate actin polymerization |
| 04/02/1997 | EP0765884A1 Anti-inflammatory compound |
| 04/02/1997 | EP0765871A1 Substituted Quinoline-2-carboxamides, their preparation and their use as prolyle-4-hydroxylase Inhibitors |
| 04/02/1997 | EP0765867A1 Substituted benzoyl guanidines, process for their preparation, their use as antiarrhythmics or diagnostic agent as well as pharmaceuticals containing them |
| 04/02/1997 | EP0765668A1 Extract of Iridaceas and composition containing it |
| 04/02/1997 | EP0765392A1 Interleukin-5 specific recombinant antibodies |